
Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …

Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …

The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the …

The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …

The biggest news this week came from Israeli biotech Zion Medical after it was announced that HIV drug Gammora was …

Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …

Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …

Politics played a big role in pharma this week after Trump introduced legislation aimed at reducing the price of drugs. …

As September came to a close and October began the UK was hit hard in the headlines after American firm …

Manufacturing took a hit this week as Novo Nordisk announced the loss of 400 jobs while Novartis made the move …

With the Pharmafocus team having avoided hurricane Florence and finally arriving back in the UK just last night, after stopping …

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …

As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …

This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …

There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …